Lantern Pharma, Inc. (LTRN)
3.82
+0.07
(+1.87%)
USD |
NASDAQ |
Jun 09, 16:00
3.80
-0.02
(-0.52%)
After-Hours: 20:00
Lantern Pharma SG&A Expense (Quarterly) : 1.680M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Replimune Group, Inc. | 18.73M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Oncolytics Biotech, Inc. | 4.729M |
| Sangamo Therapeutics, Inc. | 6.818M |
| Sarepta Therapeutics, Inc. | 108.95M |